Home
Conditions
Leukemia, Myeloid

Clinical trial condition

Leukemia, Myeloid

Explore clinical trials studying Leukemia, Myeloid. Study availability and eligibility vary by location and protocol.

3,104 public trials 618 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myeloid trial results

Completed

Vorinostat and Decitabine in Treating Patients With Relapsed, Refractory, or Poor-Prognosis Hematologic Cancer or Other Diseases

NCT00357708

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +33 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

NCT00004918

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Anemia, +23 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

NCT00027560

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +54 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

STI571 Compared With Interferon Alfa Plus Cytarabine in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia

NCT00006343

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Novartis Pharmaceuticals Corporation East Hanover, New Jersey, United States

View Trial Details

Completed

Efficacy of 5-azacytidine Added to Standard Primary Therapy in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

NCT00915252

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: RWTH Aachen, Medizinische Klinik IV Aachen, Germany

Sozialstiftung Bamberg, Klinikum am Bruderwald, Med. Klinik V Bamberg, Germany

Klinikum Bayreuth, Medizinische Klinik IV Bayreuth, Germany

Charite Campus Benjamin Franklin, Universitätsmedizin Berlin, Medizinische Klinik III Berlin, Germany

View all 27 locations

View Trial Details

Completed

Sibling and Unrelated Donor Hematopoietic Cell Transplant in Hematologic Malignancies

NCT00186342

Conditions: Acute Disease, Blood and Marrow Transplant (BMT), Bone Marrow Diseases, +15 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

NCT00136084

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: Stanford University Medical Center Palo Alto, California, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Children's Hospital of Michigan (Wayne State University) Detroit, Michigan, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Completed

Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant

NCT00920842

Conditions: Bone Marrow Diseases, Cardiovascular Complications, Chronic Disease, +25 more
Locations: Clinical Research Center - Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Completed

Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia

NCT00002925

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: University of California San Diego Cancer Center La Jolla, California, United States

UCSF Cancer Center and Cancer Research Institute San Francisco, California, United States

CCOP - Christiana Care Health Services Wilmington, Delaware, United States

Walter Reed Army Medical Center Washington D.C., District of Columbia, United States

View all 33 locations

View Trial Details

Completed

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

NCT00305708

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +32 more
Locations: UCSF Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Leukemia, Myeloid

Leukemia, Myeloid trial results

Related conditions